Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Tandem Diabetes Care, Inc. (TNDM) had Revenue of $940.20M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$940.20M
Net Income	$-96.03M
Cost of Goods Sold	$450.63M
Gross Profit	$489.57M
Operating Expenses	$1.04B
Operating Income	$-99.13M
Non-Operating Income/Expense	$7.26M
Pre-Tax Income	$-91.87M
Normalized Pre-Tax Income	$-91.87M
Income after Taxes	$-96.03M
Income from Continuous Operations	$-96.03M
Consolidated Net Income/Loss	$-96.03M
Normalized Income after Taxes	$-96.03M
EBIT	$-99.13M
EBITDA	$-82.75M
Weighted-Average Shares Outstanding (Basic)	65.45M
Weighted-Average Shares Outstanding (Diluted)	65.45M
Earnings per Share (EPS) (Basic)	$-1.47
Earnings per Share (EPS) (Diluted)	$-1.47
Balance Sheet Financials
Current Assets	$724.49M
Property, Plant, and Equipment	$78.15M
Long-Term Assets	$243.17M
Total Assets	$967.66M
Current Liabilities	$247.05M
Long-Term Debt	$308.27M
Long-Term Liabilities	$457.51M
Total Liabilities	$704.56M
Common Equity	$263.10M
Tangible Shareholders Equity	$263.10M
Shareholders Equity	$263.10M
Common Shares Outstanding	66.26M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$24.23M
Cash Flow from Investing Activities	$-23.48M
Cash Flow from Financial Activities	$8.37M
Beginning Cash	$58.87M
End Cash	$69.23M
Increase/Decrease in Cash	$10.37M
Stock-Based Compensation	$101.38M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.93
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.54
Debt to Equity Ratio	1.33
Gross Margin	52.07%
Operating Margin	-10.54%
EBIT Margin	-10.54%
EBITDA Margin	-8.80%
Pre-Tax Profit Margin	-9.77%
Profit Margin	-10.21%
Free Cash Flow	$4.99M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.97
Inventory Turnover	3.01
Receiveable Turnover	8.21
Days Sales in Receivables	44.48
Return on Equity	-36.50%
Return on Tangible Equity	-36.50%
Return on Assets	-9.92%
Return on Investments	-16.81%
Book Value Per Share	$3.97
Free Cash Flow per Share	$0.08
Operating Cash Flow per Share	$0.37

Data from Zacks Investment Research, Inc.